Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Travis Lewis, MD, PhD
Prevail Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital, Brain & Mind Research Institute, 94 Mallet Street
Camperdown, New South Wales, Australia
- Uz Leuven, Neurologie Herestraat 49
Leuven, Belgium
- Ap-Hm Hôpital de la Timone
Saint-Pierre, Marseille, France
- Centre Mémoire de Ressources
Lille, France
- Le Ber, Institut Du Cerveau Et de la Moelle Epinière
Paris, France
- Hospital Clinic de Barcelona, Villaroel 170 Servicio de Neurología
Barcelona, Spain
- Hospital Universitario de Donostia, Servicio de Neurologia, Consultas Externas Neurologia, San Sebastian, Guipúzcoa
Donostia / San Sebastian, Spain
- University College London,queen Square, Dementia Research Building, London,
London, United Kingdom
- K2 Medical Research-Maitland
Maitland, Florida, United States
- Ppd Phase 1 Clinic, 100 West Gore Street, Suite 202
Orlando, Florida, United States
- Lahey Hospital & Medical Center, 41 Burlington Mall Road
Burlington, Massachusetts, United States
- Hospital of the University of Pennsylvania, 3 West Gates Building, 3400 Spruce Street
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Nov 2020
- Primary completion
- 30 Nov 2029
- Completion
- 30 Nov 2029
- Last update posted
- 30 Apr 2026
- Registered enrollment
- 35
- Registry id
- NCT04408625
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.